| Literature DB >> 23332368 |
Alessia Carocci1, Alessia Catalano, Claudio Bruno, Angelo Lovece, Maria Grazia Roselli, Maria Maddalena Cavalluzzi, Francesco De Santis, Annalisa De Palma, Maria Rosaria Rusciano, Maddalena Illario, Carlo Franchini, Giovanni Lentini.
Abstract
Recently a series of chiral N-(phenoxyalkyl)amides have been reported as potent MT(1) and MT(2) melatonergic ligands. Some of these compounds were selected and tested for their antioxidant properties by measuring their reducing effect against oxidation of 2',7'-dichlorodihydrofluorescein (DCFH) in the DCFH-diacetate (DCFH-DA) assay. Among the tested compounds, N-[2-(3-methoxyphenoxy)propyl]butanamide displayed potent antioxidant activity that was stereoselective, the (R)-enantiomer performing as the eutomer. This compound displayed strong cytoprotective activity against H(2)O(2)-induced cytotoxicity resulting slightly more active than melatonin, and performed as Ca(2+)/calmodulin-dependent kinase II (CaMKII) inhibitor, too.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23332368 DOI: 10.1016/j.bmc.2012.12.017
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641